Holen Sie sich die Stockscreener-App
437.00
0.51%
2.2175
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HCA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$434.78
Offen:
$435.79
24-Stunden-Volumen:
938.00K
Relative Volume:
0.83
Marktkapitalisierung:
$97.29B
Einnahmen:
$76.39B
Nettoeinkommen (Verlust:
$7.81B
KGV:
15.03
EPS:
29.0772
Netto-Cashflow:
$7.93B
1W Leistung:
-7.81%
1M Leistung:
-6.59%
6M Leistung:
-6.38%
1J Leistung:
+26.64%
1-Tages-Spanne:
$426.70
$439.13
1-Wochen-Bereich:
$422.19
$452.39
52-Wochen-Spanne:
$330.00
$556.52
Hca Healthcare Inc Stock (HCA) Company Profile
Firmenname
Hca Healthcare Inc
Sektor
Branche
Telefon
(615) 344-9551
Adresse
ONE PARK PLZ, NASHVILLE, TN
Compare HCA vs THC, FMS, ENSG, UHS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCA
Hca Healthcare Inc
|
437.26 | 96.10B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
179.19 | 15.55B | 21.31B | 2.37B | 2.53B | 15.49 |
FMS
Fresenius Medical Care Ag Adr
|
22.66 | 12.30B | 22.18B | 1.36B | 2.00B | 1.9216 |
ENSG
Ensign Group Inc
|
186.41 | 11.00B | 5.06B | 344.26M | 370.71M | 5.8446 |
UHS
Universal Health Services Inc
|
167.85 | 9.92B | 17.36B | 1.51B | 849.25M | 23.15 |
Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-10-14 | Fortgesetzt | Goldman | Buy |
| 2025-07-28 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-07-16 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-29 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-11-22 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-09-03 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Fortgesetzt | JP Morgan | Neutral |
| 2022-07-06 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-29 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-24 | Eingeleitet | UBS | Buy |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-13 | Fortgesetzt | Citigroup | Neutral |
| 2021-04-26 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-07-13 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-06 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-07-10 | Hochstufung | Goldman | Neutral → Buy |
| 2019-04-23 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-11-16 | Eingeleitet | UBS | Buy |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2018-01-03 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-11-30 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-11-06 | Bestätigt | Citigroup | Neutral |
| 2017-11-01 | Bestätigt | Mizuho | Buy |
| 2017-07-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-06-28 | Eingeleitet | Argus | Buy |
Alle ansehen
Hca Healthcare Inc Aktie (HCA) Neueste Nachrichten
Vanguard Capital Management holds 11.7M HCA shares (NYSE: HCA) - Stock Titan
HCA opens downtown Orlando's first freestanding ER - The Business Journals
HCA Healthcare Stock (US40412C1018): Q1 2026 Earnings Release Expected Today - AD HOC NEWS
HCA Healthcare (HCA): A Target Cut, But Execution Still Gets Credit - Yahoo Finance
HCA Healthcare (NYSE: HCA) lifts Q1 2026 revenue and EPS to $7.15 - Stock Titan
Is HCA Healthcare Stock Undervalued Stock Or Value Trap? - Trefis
HCA Healthcare, Inc. $HCA Shares Purchased by Narwhal Capital Management - MarketBeat
Pictet Asset Management Holding SA Sells 16,605 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
Mitsubishi UFJ Trust & Banking Corp Has $40.27 Million Holdings in HCA Healthcare, Inc. $HCA - MarketBeat
Comerica Bank Sells 3,248 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
This Week's Healthcare Earnings: Elevance, HCA And More - Law360
HCA Healthcare Stockholders Reaffirm Board and Governance Structure - TipRanks
HCA Healthcare Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
HCA Healthcare (HCA) shareholders elect directors, back pay plan, reject proposals - Stock Titan
HCA Healthcare Inc Stock (HCA) Closed Down by 3.23% on Apr 28: Drivers Behind the Movement - TradingKey
Congress grills hospital CEOs over costs - Modern Healthcare
HCA Healthcare beats quarterly profit estimates on medical care demand - MSN
HCA Healthcare Inc. stock underperforms Friday when compared to competitors - MSN
Bernstein SocGen cuts HCA Healthcare price target on weather headwinds - Investing.com
Sanford C. Bernstein Lowers HCA Healthcare (NYSE:HCA) Price Target to $503.00 - MarketBeat
Deutsche Bank Aktiengesellschaft Has Lowered Expectations for HCA Healthcare (NYSE:HCA) Stock Price - MarketBeat
Deutsche Bank Adjusts HCA Healthcare Price Target to $540 From $558, Maintains Buy Rating - marketscreener.com
HCA DCF Analysis: Intrinsic Value $765 vs Price $446 - GuruFocus
HCA Healthcare prices senior notes offering of up to $3 billionfiling - marketscreener.com
Bernstein Adjusts Price Target on HCA Healthcare to $503 From $541, Maintains Market Perform Rating - marketscreener.com
State of Michigan Retirement System Has $19.52 Million Stake in HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare, Inc. $HCA Stock Holdings Lifted by Advisors Capital Management LLC - MarketBeat
HCA Healthcare Launches Note Offering to Refinance 2026 Debt - TipRanks
HCA Healthcare Inc (HCA) Stock Price, Trades & News - GuruFocus
HCA Healthcare Q1 Earnings Call Highlights - MarketBeat
HCA Healthcare names Cynthia Cifuentes-Finkel marketing chief - Investing.com
HCA Healthcare Names Cynthia Cifuentes-Finkel Senior Vice President of Marketing and Corporate Affairs - Business Wire
HCA (NYSE: HCA) plans senior notes sale to redeem 2026 issues - Stock Titan
HCA Healthcare Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
HCA Healthcare Q3 2025 Earnings Preview - MSN
HCA Healthcare hospitals earn 26 Press Ganey Human Experience Awards for patient experience - HCA Healthcare Today
How The Investment Story For HCA Healthcare (HCA) Is Shifting Around AI And Medicaid Assumptions - Yahoo Finance
HCA Healthcare Market Update: Index Signals Shape Healthcare View - Kalkine Media
HCA Healthcare Pressure Expected to Persist Through Q2 on Managed Care Rotation, RBC Says - marketscreener.com
HCA Maintained by TD Cowen -- Price Target Lowered to $500 - GuruFocus
HCA Healthcare Q1 2026 Earnings: Revenue $19.11B, EPS $7.15, Miss on EBITDANews and Statistics - IndexBox
These analysts slash their forecasts on HCA Healthcare after Q1 results - MSN
HCA Maintained by Barclays -- Price Target Lowered to $496 - GuruFocus
HCA Healthcare Stock Fell 9% After Q1 2026 Earnings. Was the Selloff Justified? - TIKR.com
ACA subsidy lapse cost HCA Healthcare $150M in Q1 - Healthcare Dive
HCA Maintained by Stephens & Co. -- Price Target Lowered to $530 - GuruFocus
HCA Healthcare drops despite Q1 beat as volume weakness concerns investors - MSN
HCA Maintains Overweight Rating -- Price Target Lowered to $510 - GuruFocus
HCA Maintained by Oppenheimer -- Price Target Lowered to $520 - GuruFocus
Truist cuts HCA Healthcare stock price target on weaker volumes - Investing.com
Stephens Issues Pessimistic Forecast for HCA Healthcare (NYSE:HCA) Stock Price - MarketBeat
Finanzdaten der Hca Healthcare Inc-Aktie (HCA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Hca Healthcare Inc-Aktie (HCA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| McAlevey Michael R | EVP & Chief Legal & Admin Off. |
Feb 18 '26 |
Sale |
533.37 |
1,694 |
903,537 |
8,853 |
0.74%
2.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):